Drug Interactions between Bactrim DS and Fe Caps
This report displays the potential drug interactions for the following 2 drugs:
- Bactrim DS (sulfamethoxazole/trimethoprim)
- Fe Caps (ferrous sulfate)
Interactions between your drugs
No interactions were found between Bactrim DS and Fe Caps. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Bactrim DS
A total of 452 drugs are known to interact with Bactrim DS.
- Bactrim ds is in the drug class sulfonamides.
-
Bactrim ds is used to treat the following conditions:
- Bacterial Infection
- Bacterial Skin Infection
- Bronchitis
- Diverticulitis
- Epiglottitis
- Granuloma Inguinale
- Infection Prophylaxis
- Kidney Infections
- Melioidosis
- Meningitis
- Middle Ear Infections
- Nocardiosis
- Pneumocystis Pneumonia
- Pneumocystis Pneumonia Prophylaxis
- Pneumonia
- Prevention of Bladder infection
- Prostatitis
- Shigellosis
- Sinusitis
- Toxoplasmosis
- Toxoplasmosis, Prophylaxis
- Traveler's Diarrhea
- Upper Respiratory Tract Infection
- Urinary Tract Infection
Fe Caps
A total of 88 drugs are known to interact with Fe Caps.
- Fe caps is in the drug class iron products.
- Fe caps is used to treat the following conditions:
Drug and food interactions
ferrous sulfate food
Applies to: Fe Caps (ferrous sulfate)
ADJUST DOSING INTERVAL: Concomitant use of some oral medications may reduce the bioavailability of orally administered iron, and vice versa.
Food taken in conjunction with oral iron supplements may reduce the bioavailability of the iron. However, in many patients intolerable gastrointestinal side effects occur necessitating administration with food.
MANAGEMENT: Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect. Some studies suggest administration of iron with ascorbic acid may enhance bioavailability. In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased. Consult the product labeling for specific separation times and monitor clinical responses as appropriate.
References (2)
- "Product Information. Feosol (ferrous sulfate)." SmithKline Beecham
- (2021) "Product Information. Accrufer (ferric maltol)." Shield Therapeutics
sulfamethoxazole food
Applies to: Bactrim DS (sulfamethoxazole / trimethoprim)
MONITOR: Two cases have been reported in which patients on sulfamethoxazole-trimethoprim therapy, after consuming beer, reported flushing, heart palpitations, dyspnea, headache, and nausea (disulfiram - alcohol type reactions). First-generation sulfonylureas have been reported to cause facial flushing when administered with alcohol by inhibiting acetaldehyde dehydrogenase and subsequently causing acetaldehyde accumulation. Since sulfamethoxazole is chemically related to first-generation sulfonylureas, a disulfiram-like reaction with products containing sulfamethoxazole is theoretically possible. However, pharmacokinetic/pharmacodynamic data are lacking and in addition, the two reported cases cannot be clearly attributed to the concomitant use of sulfamethoxazole-trimethoprim and alcohol.
MANAGEMENT: Patients should be alerted to the potential for this interaction and although the risk for this interaction is minimal, caution is recommended while taking sulfamethoxazole-trimethoprim concomitantly with alcohol.
References (2)
- Heelon MW, White M (1998) "Disulfiram-cotrimoxazole reaction." Pharmacotherapy, 18, p. 869-70
- Mergenhagen KA, Wattengel BA, Skelly MK, Clark CM, Russo TA (2020) "Fact versus fiction: a review of the evidence behind alcohol and antibiotic interactions." Antimicrob Agents Chemother, 64, e02167-19
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.